A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Comparative Study of FV-100 vs. Valacyclovir in Patients With Herpes Zoster.

Trial Profile

A Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Comparative Study of FV-100 vs. Valacyclovir in Patients With Herpes Zoster.

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Apr 2013

At a glance

  • Drugs Valnivudine (Primary) ; Valaciclovir
  • Indications Herpes zoster
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Dec 2010 Top-line results were reported in an Inhibitex media release.
    • 08 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Oct 2010 Enrollment completed, according to an Inhibitex media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top